Drimva

GSK

Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

$204K–$340K

USA - Pennsylvania - Upper Providence +5 · Remote · Director · Full-time · Posted Oct 20, 2026

Location
USA - Pennsylvania - Upper Providence
USA - Massachusetts - Waltham
UK – London – New Oxford Street
Baar Onyx
Rockville Tower Oaks Blvd
Durham Blackwell Street
Experience
3+ years of pharmaceutical industry experience; no separate duration stated for other experience.
Education
MSc, or equivalent in health outcomes, health economics, epidemiology, pharmacy, health or life sciences.

About the job

Leads oncology real-world evidence and health outcomes research to support evidence-based product positioning, reimbursement, patient access, and commercial success.

What you'll do

  • Plan, design, and oversee multiple studies, including timelines, deliverables, budgets, and quality review.
  • Translate evidence needs into study concepts and advise internal and external experts on research design and data sources.
  • Build cross-functional and external relationships, align evidence with customer and HTA needs, and report plans to stakeholders.

What they ask for

  • MSc or equivalent in health outcomes, health economics, epidemiology, pharmacy, health, or life sciences.
  • 3+ years of pharmaceutical industry experience; experience in Oncology or Hematology.
  • Experience planning and delivering projects, managing budgets, and working in a matrix setting.
  • Experience designing RWE studies and using evidence for HTA submissions, reimbursement, or medical engagements.

Nice to have

  • Advanced scientific degree, e.g. PhD, PharmD or equivalent in Health Economics, Outcomes Research, Epidemiology or similar.
  • Experience in prostate cancer, global and country oncology roles, or launch experience.

Pay

$204,000 to $340,000 USD annual base salary (Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA); $204,000 to $340,000 USD annual base salary (another US location)

Tools

Real World Evidence (RWE)

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)